← Back to Screener
Dr. Reddy's Laboratories Limited American Depositary Shares (RDY)
Price$13.24
Value ScoreD
Growth ScoreD
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)-4.51%
Price vs S&P 500 (4W)-1.29%
VGM Score44.79
Market Capitalization$11.06B
P/E Ratio (Annual)25.10x
Indicated Dividend Yield (Annual)0.63%
All Metrics
P/CF (Annual)18.57x
Book Value / Share (Quarterly)$4.78
P/TBV (Annual)4.00x
Indicated Dividend (Annual)$0.08
Revenue Growth (3Y)10.96%
Cash Flow / Share (Quarterly)$0.23
Payout Ratio (TTM)49.43%
Price vs S&P 500 (YTD)-6.20%
Gross Margin (TTM)63.68%
Net Profit Margin (TTM)12.45%
EPS (TTM)$0.53
10-Day Avg Trading Volume2.13M
EPS Excl Extra (TTM)$0.53
Revenue Growth (5Y)12.09%
EPS (Annual)$0.53
Dividend / Share (Annual)$0.08
ROI (Annual)14.79%
Gross Margin (Annual)63.68%
Net Profit Margin (5Y Avg)15.62%
Cash / Share (Quarterly)$1.18
P/E Basic Excl Extra (TTM)25.10x
Revenue Growth QoQ (YoY)-11.51%
EPS Growth (5Y)-15.60%
P/E Normalized (Annual)25.10x
ROA (Last FY)11.44%
Revenue Growth TTM (YoY)3.24%
EBITD / Share (TTM)$0.30
ROE (5Y Avg)15.68%
Operating Margin (TTM)13.04%
Cash Flow / Share (Annual)$0.15
P/B Ratio2.78x
P/B Ratio (Quarterly)2.76x
Net Income / Employee (Annual)$16,346
EV / Revenue (TTM)6.81x
Net Interest Coverage (TTM)15.96x
ROA (TTM)2.79%
EPS Growth QoQ (YoY)-86.13%
EV / EBITDA (TTM)46.62x
EPS Incl Extra (Annual)$0.53
Current Ratio (Annual)1.92x
Quick Ratio (Quarterly)1.34x
3-Month Avg Trading Volume2.24M
52-Week Price Return29.85%
EV / Free Cash Flow (Annual)60.84x
P/E Incl Extra (TTM)25.10x
Revenue / Employee (TTM)$131,284
Tangible BV / Share (Quarterly)$3.45
P/S Ratio (Annual)3.13x
Asset Turnover (Annual)0.66x
52-Week High$1379.70
Operating Margin (5Y Avg)18.15%
EPS Excl Extra (Annual)$0.53
CapEx CAGR (5Y)25.05%
Tangible BV CAGR (5Y)13.06%
26-Week Price Return3.41%
Quick Ratio (Annual)1.32x
13-Week Price Return-2.87%
Total Debt / Equity (Annual)0.14x
Current Ratio (Quarterly)1.80x
Enterprise Value$11.71B
Revenue / Share Growth (5Y)-18.83%
Asset Turnover (TTM)0.29x
Book Value / Share Growth (5Y)-15.57%
Revenue / Employee (Annual)$131,284
Inventory Turnover (Annual)1.54x
Pretax Margin (Annual)16.00%
Cash / Share (Annual)$0.73
3-Month Return Std Dev29.81%
Gross Margin (5Y Avg)65.59%
Net Income / Employee (TTM)$16,346
EBITDA CAGR (5Y)11.22%
EBITDA Interim CAGR (5Y)-18.34%
ROE (Last FY)16.86%
Net Interest Coverage (Annual)15.96x
EPS Basic Excl Extra (Annual)$0.53
P/FCF (TTM)57.46x
Receivables Turnover (TTM)3.52x
EV / Free Cash Flow (TTM)60.84x
Total Debt / Equity (Quarterly)0.20x
EPS Incl Extra (TTM)$0.53
Receivables Turnover (Annual)3.82x
ROI (TTM)3.58%
Dividend Growth Rate (5Y)-19.44%
P/S Ratio (TTM)3.13x
Pretax Margin (5Y Avg)20.79%
Revenue / Share (Annual)$4.24
Tangible BV / Share (Annual)$3.01
Forward P/E24.28x
Free OCF CAGR (5Y)-4.55%
Price vs S&P 500 (52W)20.79%
P/E Ratio (TTM)25.10x
EPS Growth TTM (YoY)-25.74%
Year-to-Date Return0.41%
5-Day Price Return-0.65%
EPS Normalized (Annual)$0.53
ROA (5Y Avg)10.88%
Net Profit Margin (Annual)12.45%
Month-to-Date Return-3.17%
Cash Flow / Share (TTM)$4.07
EBITD / Share (Annual)$0.83
EPS Growth (3Y)-2.41%
Operating Margin (Annual)13.46%
LT Debt / Equity (Annual)0.01x
P/CF (TTM)18.57x
ROI (5Y Avg)14.13%
P/E Excl Extra (TTM)25.10x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$0.53
P/TBV (Quarterly)3.82x
Payout Ratio (Annual)15.87%
P/B Ratio (Annual)2.84x
Dividend / Share (TTM)$0.08
Inventory Turnover (TTM)1.66x
Pretax Margin (TTM)16.00%
Book Value / Share (Annual)$4.23
Price vs S&P 500 (13W)-11.13%
Net Margin Growth (5Y)3.97%
Dividend Yield (TTM)0.63%
Beta0.13x
P/FCF (Annual)57.46x
Revenue / Share (TTM)$4.24
ROE (TTM)4.24%
52-Week Low$1148.40
vGradeD
gGradeD
mGradeB
vgmGradeC
Show chart for
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
3.36
3.38
3.32
3.36
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
RDYDr. Reddy's Laboratories Limited American Depositary Shares | D | D | B | $13.24 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Dr. Reddy's is one of the world's largest generic pharmaceutical manufacturers with diversified operations spanning generic drugs, injectables, and active pharmaceutical ingredients. The company generates approximately half its generics revenue from North America, with additional significant contributions from India (20%), Russia (10%), and other international markets; injectables represent 25% of North American sales. The company maintains top-five market positions in key Indian therapeutic areas including oncology and gastroenterology through its branded generics portfolio. Its API division manufactures 150+ active ingredients supplied across more than 75 countries.